Publisher
Springer Berlin Heidelberg
Reference58 articles.
1. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K (1996) The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg Am 21:210–215
2. Bani D, Yue SK, Bigazzi M (2009) Clinical profile of relaxin, a possible new drug for human use. Curr Drug Saf 16:915–928
3. Bathgate RAD, Samuel CS, Burazin TCD, Layfield S, Claasz AA, Reytomas IGT, Dawson NF, Zhao C, Bond C, Summers RJ, Parry LJ, Wade JD, Tregear GW (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. J Biol Chem 277:1148–1157
4. Bathgate RAD, Hsueh AJ, Sherwood OD (2006a) Physiology and molecular biology of the relaxin peptide family. In: Knobil E, Neill JD (eds) Physiology of reproduction, 3rd edn. Elsevier, New York
5. Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006b) International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:7–31